The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters or search function to help find relevant consultations.
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (77)
- Therapeutic goods regulation (18)
- Prescription medicines (15)
- Over the counter (OTC) medicines (14)
- Legislation (12)
- Complementary medicines (11)
- Advisory bodies and committees (10)
- Non-prescription medicines (10)
- Listed medicines (9)
- Labelling and packaging (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (4)
- Medical devices safety (4)
- Advertising (3)
- Biological medicines (3)
- Medicine safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Registered complementary medicines (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Search
251 result(s) found, displaying 76 to 100
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 31 January 2022
-
ConsultationThe TGA is conducting a public consultation on potential options for the regulation of biologicals manufactured in Australia for export only (and not for supply in Australia). Closing date: 20 December 2021
-
ConsultationThe TGA sought feedback on a Discussion paper on potential changes to mandatory reporting of medical device adverse events.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23 June 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-24 June 2021 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThe consultation period on changes to the assistive technologies exemption has been extended to 22 October 2021.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 7 October 2021
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
Consultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Triptans
ConsultationOutcomes of the consultation and submissions received have now been published -
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationThe outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published
-
ConsultationThe public consultation for the Proposed refinements to the requirements for medical device patient information materials.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 17-18 March 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationSubmissions published and summarised as part of a consultation on medical devices that are substances for introduction into the body.
-
ConsultationThe closing date has been extended and now closes on 14 July
-
ConsultationThe TGA is seeking feedback on a proposal to remake some of the legislative instruments relating to human cell and tissue (HCT) products (including blood and blood components), which sunset in October 2021. Closing date: 11 July 2021
-
ConsultationThe outcomes of the public consultation into proposed improvements to the Therapeutic Goods Advertising Code have been published.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 4 June 2021
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 27 May 2021
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 27 May 2021
-
ConsultationProposed amendments to the Poisons Standard, including substances in hand sanitisers. Closing date: 27 May 2021
-
ConsultationThe closing date for this consultation has been extended until 27 May 2021